NM_001128164.2:c.1212A>G

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BA1

The NM_001128164.2(ATXN1):​c.1212A>G​(p.Glu404Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.236 in 1,613,450 control chromosomes in the GnomAD database, including 49,845 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars).

Frequency

Genomes: 𝑓 0.29 ( 7123 hom., cov: 32)
Exomes 𝑓: 0.23 ( 42722 hom. )

Consequence

ATXN1
NM_001128164.2 synonymous

Scores

2

Clinical Significance

Likely benign no assertion criteria provided B:1

Conservation

PhyloP100: 0.0320

Publications

15 publications found
Variant links:
Genes affected
ATXN1 (HGNC:10548): (ataxin 1) The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the `pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. The function of the ataxins is not known. This locus has been mapped to chromosome 6, and it has been determined that the diseased allele contains 40-83 CAG repeats, compared to 6-39 in the normal allele, and is associated with spinocerebellar ataxia type 1 (SCA1). Alternative splicing results in multiple transcript variants, with one variant encoding multiple distinct proteins, ATXN1 and Alt-ATXN1, due to the use of overlapping alternate reading frames. [provided by RefSeq, Nov 2017]
ATXN1 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 1
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 6-16327099-T-C is Benign according to our data. Variant chr6-16327099-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 128498.Status of the report is no_assertion_criteria_provided, 0 stars.
BP7
Synonymous conserved (PhyloP=0.032 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.463 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATXN1NM_001128164.2 linkc.1212A>G p.Glu404Glu synonymous_variant Exon 7 of 8 ENST00000436367.6 NP_001121636.1 P54253-1Q96FF1
ATXN1NM_000332.4 linkc.1212A>G p.Glu404Glu synonymous_variant Exon 8 of 9 NP_000323.2 P54253-1Q96FF1
ATXN1NM_001357857.2 linkc.*625A>G 3_prime_UTR_variant Exon 8 of 9 NP_001344786.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATXN1ENST00000436367.6 linkc.1212A>G p.Glu404Glu synonymous_variant Exon 7 of 8 1 NM_001128164.2 ENSP00000416360.1 P54253-1
ATXN1ENST00000244769.8 linkc.1212A>G p.Glu404Glu synonymous_variant Exon 8 of 9 1 ENSP00000244769.3 P54253-1

Frequencies

GnomAD3 genomes
AF:
0.286
AC:
43462
AN:
151938
Hom.:
7104
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.437
Gnomad AMI
AF:
0.0802
Gnomad AMR
AF:
0.249
Gnomad ASJ
AF:
0.210
Gnomad EAS
AF:
0.479
Gnomad SAS
AF:
0.372
Gnomad FIN
AF:
0.173
Gnomad MID
AF:
0.291
Gnomad NFE
AF:
0.206
Gnomad OTH
AF:
0.286
GnomAD2 exomes
AF:
0.264
AC:
66340
AN:
250906
AF XY:
0.264
show subpopulations
Gnomad AFR exome
AF:
0.445
Gnomad AMR exome
AF:
0.222
Gnomad ASJ exome
AF:
0.217
Gnomad EAS exome
AF:
0.503
Gnomad FIN exome
AF:
0.179
Gnomad NFE exome
AF:
0.206
Gnomad OTH exome
AF:
0.239
GnomAD4 exome
AF:
0.231
AC:
337942
AN:
1461394
Hom.:
42722
Cov.:
91
AF XY:
0.235
AC XY:
170535
AN XY:
727034
show subpopulations
African (AFR)
AF:
0.449
AC:
15047
AN:
33480
American (AMR)
AF:
0.226
AC:
10112
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.208
AC:
5436
AN:
26136
East Asian (EAS)
AF:
0.480
AC:
19040
AN:
39700
South Asian (SAS)
AF:
0.362
AC:
31207
AN:
86258
European-Finnish (FIN)
AF:
0.185
AC:
9775
AN:
52934
Middle Eastern (MID)
AF:
0.239
AC:
1378
AN:
5768
European-Non Finnish (NFE)
AF:
0.208
AC:
230808
AN:
1112002
Other (OTH)
AF:
0.251
AC:
15139
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
18849
37699
56548
75398
94247
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8438
16876
25314
33752
42190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.286
AC:
43517
AN:
152056
Hom.:
7123
Cov.:
32
AF XY:
0.287
AC XY:
21336
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.436
AC:
18082
AN:
41446
American (AMR)
AF:
0.249
AC:
3811
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.210
AC:
729
AN:
3468
East Asian (EAS)
AF:
0.479
AC:
2461
AN:
5140
South Asian (SAS)
AF:
0.372
AC:
1793
AN:
4824
European-Finnish (FIN)
AF:
0.173
AC:
1833
AN:
10604
Middle Eastern (MID)
AF:
0.299
AC:
88
AN:
294
European-Non Finnish (NFE)
AF:
0.206
AC:
14024
AN:
67964
Other (OTH)
AF:
0.295
AC:
623
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1556
3111
4667
6222
7778
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
440
880
1320
1760
2200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.248
Hom.:
4955
Bravo
AF:
0.298
Asia WGS
AF:
0.466
AC:
1616
AN:
3478
EpiCase
AF:
0.205
EpiControl
AF:
0.211

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

not specified Benign:1
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
5.9
DANN
Benign
0.44
PhyloP100
0.032
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2075974; hg19: chr6-16327330; COSMIC: COSV55211111; COSMIC: COSV55211111; API